All posts by imreal

Keep eCOA Off the Critical Path of Clinical Trial Startup, Upcoming Webinar Hosted by Xtalks


The featured speakers will help attendees achieve study objectives and critical timelines, by providing guidance on how to optimize and carefully manage COAs from initial risk assessment to full implementation.

In today’s patient-driven and competitive drug development landscape, healthcare organizations and related clinical studies cannot succeed without active patient insight through clinical outcome assessments (COAs). There is a growing need for the life science industry to collaborate and take a strategic approach on the patient perspective, by seamlessly incorporating COA in trials without the usual setbacks like timeline delays and increasing health authorities’ requirements. It is time to discuss how organizations can keep electronic clinical outcome assessment (eCOA) off the critical path.

In this webinar, the featured speakers will help attendees achieve study objectives and critical timelines, by providing guidance on how to optimize and carefully manage COAs from initial risk assessment to full implementation.

Discussion topics include: An introduction to different types of COAs (different types of existing scales), general process and requirements for COA use in clinical studies; The main triggers and factors that cause eCOA implementation to end up on the critical path; And how an end-to-end approach to eCOA implementation minimizes the risk of getting on the critical path.

Join the speakers in understanding how to successfully plan and implement COA use with an end-to-end approach in clinical trial startup, from COA licensing, translation and electronic versions (eCOA).

Join Brian Lillis, Director, Clinical Outcomes Technology, ICON; Hinna Rehman, Manager, Clinical Outcomes Technology, ICON; Christelle Giroudet, Account Manager, Language Services, Patient Centred Sciences, ICON; and Janick Michel, Director, Patient Centred Sciences, Client Services, Mapi Research Trust, for the live webinar on Tuesday, October 11, 2022, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Keep eCOA Off the Critical Path of Clinical Trial Startup.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

To Uplift An Emotionally Depleted Nation, Supportiv Publishes New Collection Of Motivation Resources


Supportiv | Motivation Resource Collection

Supportiv | Motivation Resource Collection

The frustration of feeling ‘stuck’ can touch every part of your life: work, family, relationships, friendships, personal growth, coping, and healing.

How can individuals move from fatigue and burnout to energy and motivation? Over 85% of the world’s adults struggle with motivation – to take initiative, to work towards goals, or even just to get out of bed in the morning.

For those struggling to motivate themselves, in a position to help others take action, or both, Supportiv’s new Motivation articles are helpful guides for the journey from burnout to motivation.

Fatigue, burnout, illness, and other causes of low energy and initiative can steal a person’s sense of hope. Without the inclination to take action, it’s hard to believe anything can or will ever change. That’s why motivation is a cornerstone of mental health and emotional wellbeing.

Unfortunately, we live in a world that drains motivation in many different ways.

Supportiv CEO Helena Plater-Zyberk explains: “Events like pandemics create a sense that you don’t have agency over what happens in your own life. Constant stimulation and demands on our time drain our energy and creativity, and our attention spans have been battered by social media. When society’s lack of personal human connection keeps us from recharging enough, it’s no wonder that most people struggle with motivation in some way or another.”

Despite the external factors contributing to global demotivation, there are ways to take action as an individual to re-energize yourself.

Supportiv Co-Founder Pouria Mojabi speaks to the wellbeing effects of motivating oneself: “A lack of motivation blocks you from fulfilling your potential. The frustration of feeling ‘stuck’ can touch every part of your life: work, family, relationships, friendships, personal growth, coping, and healing. However, we often have more control over our own initiative than we believe. This collection of articles can help readers catalyze themselves, overcoming apathy or lethargy.”

Supportiv’s new Motivation Collection (https://www.supportiv.com/motivation) covers topics such as:


  • Don’t Care About Anything? Enjoy Life Again
  • Do This To Get Yourself Out Of The House
  • Spark Action On A Daunting Task
  • Get Out Of A Rut
  • Re-Balance Yourself With A Life Inventory
  • How To Be Proud Of Your Work Ethic Without Burning Out
  • Stop Procrastination Before It Stops You
  • Emotional Readiness To Work After A Vacation
  • Rediscover Your Passions Post-Retirement
  • Self Limiting Beliefs: Unravel Them Before They Unravel You
  • Feeling Directionless? Why It Happens and How To Move On
  • What Am I Going To Do? Ways To Keep Moving Forward
  • Bite-Sized Burnout Prevention Measures
  • Choosing To Change Unhealthy Habits

Find inspiration to cultivate motivation, in the full article collection at https://www.supportiv.com/motivation.

In addition to its peer-to-peer support network, relevant Supportiv articles and tips also surface in real-time inside its 24/7 peer support chats. By typing a few words in response to the question: “What’s your struggle?” users are matched in under a minute to topic-specific peer-to-peer group chats for anonymous support–from feeling left out to family drama, from breakups to making friends, and from anxiety to apathy. Even experiences regarding anger, trauma, and discrimination are up for discussion in Supportiv’s anonymous peer support chats.

Supportiv has already enabled over 1.2 million users to feel less lonely, anxious, stressed, misunderstood, and hopeless through its moderator-guided chats with AI-driven content and resource recommendations. See what real users have to say, here: http://www.supportiv.com/users-testimonials.

Share article on social media or email:

Cecelia Health Celebrates 2022 Donnelly Scholarship Recipients


Cecelia Health today shared their participation in the 2022 Novo Nordisk Donnelly Scholarship. The two national recipients, Anne Marie Hiser (Acworth, Ga.) and Bogdan Vizoli (Woodbury, Minn.), were awarded scholarships of $10,000 each last month and celebrated at a reception during the first week of the US Open where they visited with sports icon Billie Jean King as well as leaders from Cecelia Health and other scholarship sponsors.

Winners received virtual diabetes education and support from Cecelia Health around disease management, device support, nutrition, and exercise while competing at an intense level. The company’s Certified Diabetes Care & Education Specialists (CDCES) built trusting relationships with the 2022 program athletes to better understand and manage their blood sugar levels, demonstrate improvements in their time-in-range (TIR), and learn life-long skills to successfully manage their diabetes.

“Cecelia Health is honored to support the Novo Nordisk Donnelly Scholarship program,” said Mark Clermont, chief executive officer at Cecelia Health. “The relationships our CDCES built virtually with Anne Marie and Bogdan are exemplary of the value that human connection has on achieving health goals. It is consistent with our mission, and we congratulate these remarkable award winners.”

The Novo Nordisk Donnelly Scholarships are awarded to students who completed an application that included an essay question describing how their life has been impacted by diabetes, and who are entering a four-year college or university program, intended to support the student’s cost of tuition, educational materials, and other related expenses at the college or university the student selects.

This scholarship, now in its 20th consecutive year, is named in honor of Tracey Donnelly Maltby and Diane Donnelly Stone, who along with their father, Bud Donnelly, all played Division I collegiate tennis while affected by the challenges of Type 1 diabetes.

To learn more about the impact of Cecelia Health’s virtual diabetes support on the lives of student athletes, read this blog featuring stories from 2021 winners.

About Cecelia Health

Cecelia Health delivers virtual care designed with a human element to improve health outcomes of people living with chronic conditions. From more than one million connections led by a national network of specialty providers and expert clinicians, the company understands how to motivate people to make lasting behavior change through scalable solutions that address individual needs. With a new approach to modernize the care journey, Cecelia Health amplifies human engagement and offers a truly frictionless patient experience that is proven to positively impact quality measures, reduce variability in care, and improve medication, device, and clinical trial adherence.

Share article on social media or email:

EpiBone CEO and Co-Founder Dr. Nina Tandon Selected to Participate in White House Summit


The EpiBone team is proud to play a role in driving innovation to transform the future of health and quality of life with cutting-edge technology and research in tissue engineering.

EpiBone CEO and Co-Founder Dr. Nina Tandon participated as a speaker at the White House Summit on Biotechnology & Biomanufacturing for the American Bioeconomy on September 14, 2022. The summit brought together government and private sector leaders as a first step in launching the Biden Administration’s National Biotechnology and Biomanufacturing Initiative, a whole-government approach to advancing biotechnology and biomanufacturing to create innovation in health, climate change, energy, food security, agriculture, supply chain resilience, and national and economic security.

The half-day summit included a bioeconomy roundtable discussion with government officials and private sector leaders and two panels, one exploring biotechnology for global change and another discussing biomanufacturing and the bioeconomy. Tandon spoke during the morning roundtable discussion, sharing her perspectives on biotechnology, and its relevance as the future of medicine, as well as the pressing need for government support.

“I’m humbled to have had the opportunity to speak alongside my colleagues who are all industry luminaries as part of this critical White House Summit roundtable discussing industry advancements that will help move the entire field forward,” said Tandon. “Biotechnology holds immeasurable possibility to improve the quality and capacity of our lives, and this new White House initiative speaks to that possibility while positioning the US as a global leader in the industry. The EpiBone team is proud to play a role in driving innovation to transform the future of health and increasing quality of life by bringing game-changing tissue engineered products to patients.”

As CEO and co-founder of EpiBone, Inc., Tandon bridges the realms of business and science, with decades of experience in tissue engineering and bioreactor design. She has completed a Ph.D. in biomedical engineering and an MBA from Columbia University. Tandon has been named one the 40 under 40 by Crain’s New York, an Ernst & Young Winning Woman, and one of Goldman Sachs’ 100 Most Intriguing Entrepreneurs. She is also a WEF Young Global Leader and McKinsey alumni. Tandon’s passion for science and innovation is dwarfed only by her desire to see the promise of regenerative medicine fully realized.

In her work at EpiBone, Tandon leads the company in its mission to use groundbreaking research to transform skeletal repair. The team uses advanced science and technology to solve problems that once seemed unsolvable, developing processes that uses cells to grow new bone and cartilage tissues. This work has been recently underscored by the successful implantation of all the patients in their first-in-human clinical trial using the most advanced product in their pipeline, a customized living bone graft grown from a patient’s own cells.

To learn more about Dr. Nina Tandon and the work of the EpiBone team, visit https://www.epibone.com/.

About EpiBone

EpiBone, Inc. is privately-held clinical-stage regenerative medicine company focused on skeletal reconstruction. Sitting at the intersection of biology and engineering, the company harnesses the power of cells to create living solutions that can become a seamless part of a patient’s body. EpiBone is currently developing a pipeline of bone, cartilage, and compound (bone and cartilage) products.

For more information, please visit: https://www.epibone.com/

Disclaimer

This communication contains forward-looking statements which can generally can be identified by words such as “plans,” “change,” “will,” “following”, “strengthening,” “developing, the negative of these words and similar words and expressions, which are based on EpiBone’s current expectations, assumptions, estimates and projections about its business, technology, product development and industry. Such forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially and include, without limitation, EpiBone’s ability to (1) adequately protect or enforce its intellectual property rights, (2) develop and commercialize new products and technologies on a timely basis (or at all), (3) risks associated with acquisitions and strategic investments and (4) attract and retain qualified personnel. Accordingly, you are cautioned not to place undue reliance on such forward-looking statements. Additionally, this communication does not constitute an offer to sell or a solicitation of an offer to buy securities.

Share article on social media or email:

MotherToBaby Bilingual Fact Sheets Now Included in the Prestigious National Library of Medicine


MotherToBaby Fact Sheets Now Included in the National Library of Medicine

This is just one more way we can ensure pregnant people and healthcare providers can have access to reliable, up-to-date, research-based information so they can make better informed decisions during the child-bearing journey or in cases of adoption.

The non-profit Organization of Teratology Information Specialists (OTIS) through its public-facing service, MotherToBaby, are now contributors to the prestigious National Library of Medicine (NLM) where more than 250 of its bilingual (English/Spanish) evidence-based fact sheets can be found on medications, vaccines, diseases, herbal supplements, occupational exposures and more during pregnancy and breastfeeding.

MotherToBaby provides information on exposures before and during a pregnancy as well as breastfeeding traditionally through its no-cost helpline 866-626-6847, texting service 855-999-3525 and website http://www.MotherToBaby.org, where the public can live chat or e-mail an expert. “This is just one more way we can ensure pregnant people and healthcare providers can have access to reliable, up-to-date, research-based information so they can make better informed decisions during the child-bearing journey or in cases of adoption,” said Christina Chambers, PhD, MPH, MotherToBaby Past President and UC San Diego professor of pediatrics. “Being a part of the NLM is a testament to the reliability of our resources. We are honored to be contributors.”

For more than 200 years, “the National Library of Medicine has been a partner for biological discovery, clinical care decision-making and healthcare choices in everyday living,” according to its website. The NLM includes health information tools and biomedical literature, such as PubMed. The MotherToBaby Fact Sheets through the NLM can be accessed through public and hospital libraries as well as in schools and clinics. It’s also available at the following link: https://www.ncbi.nlm.nih.gov/books/NBK582980/

More about OTIS and MotherToBaby

The Organization of Teratology Information Specialists (OTIS) is a professional scientific society made up of individuals engaged in assessing and evaluating risks to pregnancy and breastfeeding from environmental exposures. Members include, but are not limited to, specialists in the fields of obstetrics and gynecology, pediatrics, genetics, dysmorphology, perinatal epidemiology, teratology, behavioral teratology, pharmacy, genetic counseling, nursing, midwifery, maternal and child health, public health, and includes experts that provide MotherToBaby services and researchers that conduct MotherToBaby Pregnancy Studies. MotherToBaby is a suggested resource by many federal agencies including the Centers for Disease Control and Prevention (CDC). MotherToBaby is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents of this release are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS or the U.S. Government. To learn more about MotherToBaby and OTIS, please visit http://www.MotherToBaby.org.

Share article on social media or email:

Frontline Systems Releases RASON® V2023 Platform with Patent-Pending Risk Analysis for Machine Learning Models


RASON Portal Model Editor

With a patent application now on file to preserve invention rights, our RASON users are the first to benefit from these innovative methods.

Frontline Systems is shipping RASON® V2023, a new version of its cloud platform for advanced analytics, that enables both business analysts and developers to easily create and run models using mathematical optimization, Monte Carlo simulation and risk analysis, data mining and machine learning, and business rules and calculations.

RASON is not new – since 2015 it has been available “around the clock” as an Azure-based SaaS platform, one of the first to offer a REST API for both predictive and prescriptive analytics. RASON has been enriched each year with new analytics and model management features – including support for business rules using the DMN open standard in 2019. But now it’s the first and only tool with fully automated methods for risk analysis of previously trained and validated machine learning (ML) models.

Risk analysis changes the focus from how accurately a ML model will predict a single new case, to how it will perform in aggregate over thousands or millions of new cases, what the business consequences will be, and the (quantified) risk that this will be different than expected from the ML model’s training and validation.

“With a patent application now on file to preserve invention rights, our RASON users are the first to benefit from these innovative methods,” said Daniel Fylstra, Frontline’s President and CEO. Frontline Systems is concurrently releasing new versions of Solver SDK®, its object library for developers, and Analytic Solver®, its tool for business analysts using Excel for the Web, Windows and Macintosh, with support for the same innovative methods.

How and Why Machine Learning has Lacked Risk Analysis

For a decade, data science and machine learning (DSML) tools – including RASON – have offered facilities for ‘training’ a model on one set of data, ‘validating’ its performance on another set of data, and ‘testing’ it versus other ML models on a third set of data. But this is not risk analysis: based on known data, it doesn’t assess the risk that the ML model will perform differently on new data when put into production use. While it’s common to assess a ML model’s performance in use, and move to re-train the model if its performance is unexpectedly poor, by that time those risks have occurred, often with adverse financial consequences. Quantification of such risks “ahead of time” has been missing in practice.

There are many reasons for this state of affairs: Data scientists with expertise in ML methods often are not trained in risk analysis; they think of “features” and even predicted output values as data, not as “random variables” with sampled instances. Even if known, conventional risk analysis methods are expensive and time-consuming to apply to machine learning: ML data sets include many (sometimes hundreds) of features, with limited “provenance” of the data’s origins. There are hundreds of classical probability distributions that could be ‘candidates’ to fit each feature. Only some of the features are typically found, after ML model training, to have predictive value; many are found to be correlated with other features and hence ‘redundant’. And in typical projects, a great many ML models are built.

How RASON Performs Automated Risk Analysis

Unlike most cloud DSML platforms, RASON also includes powerful algorithms for risk analysis: Probability distribution fitting, correlation fitting, stratified sample generation and Monte Carlo analysis. But asking users to “quickly master risk analysis” is asking too much. So Frontline Systems has invented ways to automate the entire risk analysis process. Using the new risk analysis capability is as simple as adding text such as “simulation”: { } to the RASON definition of a machine learning model – and the risk analysis typically adds just seconds to a minute to the existing process of training, validating and testing a ML model.

Internally, for each feature in a dataset, RASON tests an entire family of probability distributions – drawing on its first-mover support for the new Metalog family of distributions, created by Dr. Tom Keelin; optimizes all the parameters of each distribution; detects and models correlations among features, using rank order and copula methods; performs synthetic data generation, using Monte Carlo methods for stratified sampling and correlation; computes the ML model’s predictions, as well as user-specified financial consequences, for each simulated case; and importantly, assesses and quantifies the differences in performance of the ML model on this simulated data versus the training, validation and test data.

Results of the risk analysis, including key summary statistics, percentiles and risk measures, are available in JSON and OData form. Users can easily request and obtain the data needed to create charts on their own Web pages or in tools like Power BI or Tableau, or perform further analysis of their own.

Synthetic Data Generation as a Side Benefit

Synthetic Data Generation (SDG) has become topical in machine learning in recent years, with a number of companies founded just to supply software and services around this technology. SDG is used when there isn’t enough original data, or when use of the original data is restricted by law or regulation. But until now (in a patent and literature search), SDG has simply been used to better train ML models.

RASON V2023 includes a powerful, general-purpose, easy to use Synthetic Data Generation facility, invoked by simply writing “algorithm”: “syntheticDataGenerator” within a data “transformer” step. Unlike some special-purpose SDG offerings, this facility can accurately model the behavior of nearly any combination of features with continuous values. But RASON also uses synthetic data in an entirely new way, to analyze the risk that a ML model will yield unexpected results “large enough to matter” when deployed for production use.

Works with Already-Available ‘Augmented Machine Learning’

RASON’s V2022 release featured “augmented machine learning” features found only in other sophisticated machine learning tools. The user simply supplies data, and in a RASON “estimator” clause, adds “algorithm”: “findBestModel” and provides a list of “Learners” of different types – classification and regression trees, neural networks, linear and logistic regression, discriminant analysis, naïve Bayes, k-nearest neighbors and more. When the model is run, RASON automatically tests and fits parameters for all of the Learners (ML algorithms) to the training data, validates and compares them according to user-chosen criteria, and delivers the trained ML model that best fits the data. Again by adding a command as simple as “simulation”: { }, the user can perform a risk analysis on the “best model” found by RASON.

Free Trials, Learning and Coaching Resources

Analysts and developers can sign up for free trial accounts to evaluate RASON at https://rason.com, exercise the REST API, try out dozens of example models using optimization and simulation, forecasting and machine learning, business rules and calculations, and download the RASON User Guide and Reference Guide in PDF form. For more information please contact sales@solver.com.

Frontline Systems Inc. (http://www.solver.com) is the alternative to analytics complexity, helping business analysts and managers gain insights and make better decisions for an uncertain future, without the cost, delays and risk of ‘big vendor’ tools. Its products integrate forecasting and data mining for “predictive analytics,” Monte Carlo simulation for risk analysis, conventional and stochastic optimization for “prescriptive analytics,” and business rules and Excel calculations to make the best business decisions. Founded in 1987, Frontline is based in Incline Village, Nevada (775-831-0300).

Microsoft Excel, Office 365, Azure and Power BI are trademarks of Microsoft Corp. Tableau is a trademark of Salesforce Inc. Analytic Solver®, RASON® and Solver SDK® are registered trademarks of Frontline Systems Inc.

Richter Welcomes Landa Stricklin as New Director of Clinical Consulting


Landa Stricklin

Landa’s passion for helping others is evident – whether client-facing or internally – and we are confident her leadership and expertise will play a vital role in enhancing outcomes for our clients.

Richter is pleased to announce Landa Stricklin as the new director of clinical consulting. In this role, Landa is responsible for leading Richter’s clinical consulting team as they provide clinical, operational and eHR solutions to long-term post-acute health care providers. By keeping apprised of federal regulations and changes across the LTPAC industry, she prepares clients to proactively meet new expectations through Richter’s custom-designed services.

Landa received her Master of Science Degree in Nursing from Kennesaw State University in 2010, and her Bachelor of Science Degree in Nursing from West Georgia State University in 2004. She also became a licensed nursing home administrator in 2007, and is a certified MDS assessment coordinator. She is an active member of the Health Care Compliance Association (HCCA), and is currently pursuing their compliance certification program.

Landa’s previous roles have included positions primarily in the skilled nursing sector, as vice president and director of clinical reimbursement, compliance director, and nursing home administrator.

“We are excited to tap into the knowledge that Landa has gained throughout her 30+-year career in the industry,” stated President and CEO Jennifer Richter. “Her passion for helping others is evident – whether client-facing or internally – and we are confident her leadership and expertise will play a vital role in enhancing outcomes for our clients.”

Click here to view Landa’s full biography.

About Richter

Led by a CPA and staffed with a team of over 70 professionals, Richter serves the entire LTPAC spectrum—from small and midsize organizations through large, multi-facility, multistate groups. Whatever your challenges may be, our trusted and experienced professionals listen, analyze, strategize, quantify, then devise and deploy customized solutions to ENHANCE OUTCOMES in every facet of your organization.

For more information on Richter, call us at (866) 806-0799 or visit http://www.richterhc.com.

Share article on social media or email:

Author Jing Carter-Lu’s new book “How to Stay Healthy During-After the Covid-19 Pandemic?” is a tool for those seeking ways to maintain their health during a pandemic


News Image

Jing Carter-Lu, an entrepreneur and inventor who worked for Weill Medical College of Cornell University for seven years as a research technician, has completed her new book “How to Stay Healthy During-After the Covid-19 Pandemic?”: an educational tool discussing the various methods one can use to remain healthy and safe despite the spread of the Covid-19 virus.

“The purpose of the book ‘How to Stay Healthy During/After COVID-19 Pandemic?’ is to help people boost their immune system with food medicine, herbal medicine, over-the-counter medicine, massage therapy, aromatherapy, exercise, etc.,” writes Carter-Lu.

“In this book, I focus on introducing preventive health maintenance methods and healing methods by using affordable food medicine, physical therapy, and over-the-counter medicines. Some of the methods I introduce in the book were handed down from generation to generation for hundreds of years for health issues, healing, and recovering from sickness. These methods make use of things you can find in your kitchen such as garlic, ginger, vinegar, etc.”

Carter-Lu continues, “Keeping the air clean at home, at school, and at the workplace is especially important for people’s health, survival, and happiness, as we have all learned from the COVID-19 virus being transferred through air. I sincerely want to introduce the new innovational product Ceiling/Floor Vent’s Eco Air Filters and Ceiling/Floor Vent’s Sanitize Air Filters (coming soon) to people to help overcome and remove the COVID-19 pandemic from our daily life.”

Published by Page Publishing, Jing Carter-Lu’s informative manual makes a healthy lifestyle approachable by reviewing simple and accessible practices that every reader can utilize no matter their current situation. From improving ventilation to making use of simple ingredients one can find in almost any pantry, Carter-Lu provides almost everything there is to know about Covid-19 safety.

Readers who wish to experience this informational work can purchase “How to Stay Healthy During-After the Covid-19 Pandemic?” at bookstores everywhere, or online at the Apple iTunes Store, Amazon, Google Play, or Barnes and Noble.

For additional information or media inquiries, contact Page Publishing at 866-315-2708.

About Page Publishing:

Page Publishing is a traditional, full-service publishing house that handles all the intricacies involved in publishing its authors’ books, including distribution in the world’s largest retail outlets and royalty generation. Page Publishing knows that authors need to be free to create, not mired in logistics like eBook conversion, establishing wholesale accounts, insurance, shipping, taxes, and so on. Page’s accomplished writers and publishing professionals allow authors to leave behind these complex and time-consuming issues and focus on their passion: writing and creating. Learn more at http://www.pagepublishing.com.

Share article on social media or email:

Winners Named in the 2022 September Christian Writers Awards Writing Contest


News Image

Xulon Press is thrilled to once again extend the opportunity to have Christian writers’ work recognized and rewarded. Besides the esteemed honor of being named the 2022 September Christian Writers Awards writing contest winner, the Grand Prize writer will also receive an Elite Publishing Package (valued at $8,780) to publish a book with Xulon Press. Out of the several hundred outstanding entries received from around the world, three winners were chosen after careful deliberation.

The 2022 September Christian Writers Awards writing contest winners are:

Grand Prize Winner

Rural Ramparts by Michelle Lapp

2nd Place

Dream of a Sari by LJ Brandt

3rd Place

Prayer Journal: 30 Days of Finding Purpose and Redefining Balance by Mirette Abraham

Congratulations to all of the winners!

Xulon Press would like to extend a big thank you and congratulations to every talented writer that participated in the 2022 September writing contest. XP invites all faith-based writers to enter the next round of the Christian Writers Award writing contest that will take place in January 2023 where you will have the opportunity to win a Publishing Package from Xulon Press and become a published author–just like these names above!

Xulon Press, a division of Salem Media Group, is the world’s largest Christian self-publisher, with more than 20,000 titles published to date.

Media Contact: Xulon Press

Email: contest@xulonpress.com

Share article on social media or email:

The Fenway Institute Offers Ways To Support Transgender and Gender Diverse Medical Students


Rectangular Blue Fenway Health Logo with White Lettering

A key factor for improving and expanding the field of transgender health is the presence of transgender and gender diverse physicians in the medical workforce.

An “Art of Medicine” perspective published in The Lancet outlines the need for physician-educators, faculty, and medical education systems to support transgender and gender diverse (TGD) medical students and offers actionable and meaningful ways to do so. The essay adds to the growing body of literature on how to improve the quality of care for TGD people and their families.

“There is great need among transgender and gender diverse children, adolescents and adults for high-quality care, and all clinicians should be trained in how to provide it,” said senior author Dr. Alex S. Keuroghlian, who directs the National LGBTQIA+ Health Education Center at The Fenway Institute and the Massachusetts General Hospital Psychiatry Gender Identity Program. “A key factor for improving and expanding the field of transgender health is the presence of transgender and gender diverse physicians in the medical workforce. Everyone who plays a role in medical education has a responsibility to support transgender and gender diverse medical students.”

The “Art of Medicine” perspective titled, “Supporting Transgender and Gender Diverse Medical Students,” suggests that cisgender physician-educators and teaching faculty can support TGD students by:


  • Learning the basics of gender identity and expression, which begins with understanding that the two are different. Gender identity refers to a person’s inner experience of gender. Gender expression refers to the ways in which a person expresses their gender with their name, pronouns, clothing, voice, and hairstyle.
  • Understanding that implicit and explicit bias against TGD people adversely impacts communication, rapport, and decision-making in clinical and education settings.
  • Introducing themselves with their name and pronouns and using students’ stated names and pronouns, thus modelling the practice for everyone, including cisgender patients.
  • Rehearsing how they will respond if they misgender a student.
  • Managing their own anti-TGD implicit bias by proactively dealing with it through anti-bias training and self-reflection.

The essay also suggests that medical education systems can support TGD students by:

  • Creating and implementing non-discrimination policies that specifically protect TGD students.
  • Implementing organizational systems, processes, and protocols to officially share all students’ correct names and pronouns with course teaching, clinical clerkship, school administration, and hospital systems staff.
  • Ensuring the availability of gender-inclusive restrooms and scrub changing areas.

“Although medical education systems were not designed with transgender and gender diverse medical students in mind, these students have shown great resilience,” said lead author Nicolas Freeman (they/them), a fourth-year medical student at Harvard Medical School. “All stakeholders in medical education have an obligation to think critically and implement strategies that will foster inclusive learning environments that will support transgender and gender diverse students in the classroom and on the wards. In this way, we can move towards a future where high-quality transgender health is more readily accessible, and transgender and gender diverse patients will see themselves reflected in the medical workforce.”

“Supporting Transgender and Gender Diverse Medical Students,” was published online by The Lancet on September 10, 2022. It is available here.

Share article on social media or email: